- Prasugrel approved with restricted label
- Senate to go after drug pricing
- The HCC best stories for H1 2009
- Chantix added box warning but stays on the market
- Great PR for pacemakers from the White House
- Paradigm changer for ortho: overhaul of the 510K system
- Pain pills cause celebrity strange behavior
- Beware The Google
- Ive been TARPed
- Doctors are not Internet savvy
- Call it Swine Flu
- Each man has his price, Bob
- Scientific American: Unsustainable cancer drug costs
- Fox Business: Doctors should be paid more
- Congressional Health Care Caucus
- Fox Business: What to monitor with swine flu
- Comparative effectiveness and NICE
- Healthcare Reform Summit on May 1
- Fox Business: FTC scrutiny of the PFE WYE merger
- Fox Business: Obama v McCain
- WSJ.com: The JUPITER trial
- Fox Business: Health of Healthcare
- The Wall Street Journal: Avastin for Breast Cancer
- Fox Business The SGP MRK merger
- Fox Business the PFE WYE proposed deal
- WSJ.com: video tutorial on dermal fillers and Botox
- The Wall Street Journal: Senator Grassley
- The Wall Street Journal: Knee arthroscopy of no benefit in o
- The Wall Street Journal: JNJ DTC TV ads on Cypher
- ABC News: Steve Jobs of Apple and his cancer
- The Wall Street Journal: Vytorin May Lose Preferred Medicare
- The Wall Street Journal: Senate Inquiry into ACC and CRF
- The Wall Street Journal: Liposuction with Dr. Fodor
- The Wall Street Journal: the Next Biotech to be Acquired?
- The Wall Street Journal: The Tysabri Re-Launch
- The Wall Street Journal: Who is Dr. Jarvik Anyway?
- Fox Business: The BMY bid for IMCL and what's next
- Fox Business: ASCO preview
- The Wall Street Journal: ASCO abstracts story
- Forbes: Waiting for ENHANCE
- The Wall Street Journal: Avastin for Brain Cancer